Market Overview:
The global everolimus tablet market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of cancer and organ transplantations, and the rising demand for targeted therapies. Based on type, the global everolimus tablet market is segmented into 2.5 mg tablets, 5 mg tablets, 7.5 mg tablets, and 10 mg tablets. The 5 mg tablet segment is expected to account for the largest share of the global everolimus tablet market in 2018 owing to its high demand as a targeted therapy for various indications such as renal cell carcinoma (RCC), pancreatic cancer, breast cancer, and others. Based on application, the global everolimus tablet market is segmented into oncology applications; organ transplant applications such as heart transplants kidney transplants liver transplants pancreas transplants small bowel transplants; gastrointestinal applications such as Crohn’s disease ulcerative colitis ileal pouch-anal anastomosis (IPAA) surgery; and other applications including rheumatoid arthritis psoriasis multiple sclerosis (MS). The oncology application segment is expected to account for the largest share of the global everolimus tablet market in 2018 owing to its high prevalence across all regions globally.
Product Definition:
Everolimus is an immunosuppressant medication used to prevent rejection of organ transplants. It may also be used to treat certain types of cancer.
2.5 mg Tablets:
2.5 mg Tablets is used for the treatment of rheumatoid arthritis and osteoarthritis, as well as chronic pain due to diabetic neuropathy or post-operative pain. It works by decreasing joint inflammation and has been found to be more effective than a 5 mg tablet in treating these conditions.
5 mg Tablets:
5 mg Tablets is used for the treatment of renal cell carcinoma and multiple myeloma. It is also used as a part of combination therapy with Everolimus (Afinitor) in the treatment of chronic myeloid leukemia. The drug was approved by the FDA in 2011 under breakthrough therapy designation for treating patients with advanced renal cell carcinoma, which could not be treated by standard chemotherapies or immunotherapies at that time.
Application Insights:
Oncology accounted for the largest revenue share in 2017 and is expected to continue its dominance over the forecast period. Everolimus is used in the treatment of various cancers such as kidney, lung, breast, colorectal and liver cancer. It has shown encouraging results against liver cancer as well as metastatic prostate cancer. However, it has not been approved by the U.S FDA for these indications yet; hence its use is limited to clinical trials only at this time.
The gastrointestinal segment held a significant market share in 2017 owing to high product usage for treating conditions such as Crohn¢â‚¬â„¢s disease and ulcerative colitis among others that are associated with low-grade inflammation of intestinal lining cells (ILC).
Regional Analysis:
North America dominated the global market in 2017, with a revenue share of over 40.0%. The growth is attributed to the presence of key players such as Pfizer Inc.; Merck & Co., Inc.; and Celgene Corporation. In addition, these companies are investing heavily in R&D activities for new drug development and clinical trials to expand their product portfolio. This factor is expected to drive regional growth during the forecast period.
Asia Pacific region is anticipated to witness lucrative CAGR over the forecast period owing to increasing healthcare expenditure by governments and private sectors coupled with growing patient awareness levels regarding advanced treatment options for various diseases including cancer, diabetes, arthritis, etc. Moreover, availability of generic drugs due to patent expirations or regulatory changes will also support Everolimus Tablets Market growth in APAC region during the same period (2018-2030).
Growth Factors:
- Everolimus Tablet is a cost-effective treatment option for cancer patients, as it is available at a lower price than other branded cancer drugs.
- Everolimus Tablet has been shown to be effective in treating various types of cancers, including breast cancer, renal cell carcinoma, and pancreatic cancer.
- The use of Everolimus Tablet in combination with other chemotherapy drugs has been found to be more effective than using the drug alone.
- Clinical trials have shown that the use of Everolimus Tablet can improve patient survival rates and quality of life. 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Everolimus Tablet Market Research Report
By Type
2.5 mg Tablets, 5 mg Tablets, 7.5 mg Tablets, 10 mg Tablets
By Application
Oncology, Organ transplant, Gastrointestinal, Others
By Companies
Novartis, Biocon, Novartis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
129
Number of Tables & Figures
91
Customization Available
Yes, the report can be customized as per your need.
Global Everolimus Tablet Market Report Segments:
The global Everolimus Tablet market is segmented on the basis of:
Types
2.5 mg Tablets, 5 mg Tablets, 7.5 mg Tablets, 10 mg Tablets
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncology, Organ transplant, Gastrointestinal, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- Biocon
- Novartis
Highlights of The Everolimus Tablet Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 2.5 mg Tablets
- 5 mg Tablets
- 7.5 mg Tablets
- 10 mg Tablets
- By Application:
- Oncology
- Organ transplant
- Gastrointestinal
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Everolimus Tablet Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Everolimus Tablet is a medication used to treat cancer. It belongs to a class of drugs called tyrosine kinase inhibitors (TKIs). Everolimus Tablet works by stopping the growth of cancer cells.
Some of the major companies in the everolimus tablet market are Novartis, Biocon, Novartis.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Everolimus Tablet Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Everolimus Tablet Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Everolimus Tablet Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Everolimus Tablet Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Everolimus Tablet Market Size & Forecast, 2020-2028
4.5.1 Everolimus Tablet Market Size and Y-o-Y Growth
4.5.2 Everolimus Tablet Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 2.5 mg Tablets
5.2.2 5 mg Tablets
5.2.3 7.5 mg Tablets
5.2.4 10 mg Tablets
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Oncology
6.2.2 Organ transplant
6.2.3 Gastrointestinal
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Everolimus Tablet Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Everolimus Tablet Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 2.5 mg Tablets
9.6.2 5 mg Tablets
9.6.3 7.5 mg Tablets
9.6.4 10 mg Tablets
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Oncology
9.10.2 Organ transplant
9.10.3 Gastrointestinal
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 2.5 mg Tablets
10.6.2 5 mg Tablets
10.6.3 7.5 mg Tablets
10.6.4 10 mg Tablets
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Oncology
10.10.2 Organ transplant
10.10.3 Gastrointestinal
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 2.5 mg Tablets
11.6.2 5 mg Tablets
11.6.3 7.5 mg Tablets
11.6.4 10 mg Tablets
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Oncology
11.10.2 Organ transplant
11.10.3 Gastrointestinal
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 2.5 mg Tablets
12.6.2 5 mg Tablets
12.6.3 7.5 mg Tablets
12.6.4 10 mg Tablets
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Oncology
12.10.2 Organ transplant
12.10.3 Gastrointestinal
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 2.5 mg Tablets
13.6.2 5 mg Tablets
13.6.3 7.5 mg Tablets
13.6.4 10 mg Tablets
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Oncology
13.10.2 Organ transplant
13.10.3 Gastrointestinal
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Everolimus Tablet Market: Competitive Dashboard
14.2 Global Everolimus Tablet Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis
14.3.2 Biocon
14.3.3 Novartis
